| known also as: |
ADRA2, ADRA2R, ADRAR, ALPHA2AAR, Alpha-2A-Adrenergic Receptor, Alpha-2AAR Subtype C10), OTTHUMP00000058849, Receptor, ZNF32, alpha-2A-, Anti-ADRA2A (Adrenergic |
| known also as: |
ADRA2, ADRA2R, ADRAR, ALPHA2AAR, Alpha-2A-Adrenergic Receptor, Alpha-2AAR Subtype C10), OTTHUMP00000058849, Receptor, ZNF32, alpha-2A-, ADRA2A (Adrenergic |
| known also as: |
ADRA2, ADRA2R, ADRAR, ALPHA2AAR, Alpha-2A-Adrenergic Receptor, Alpha-2AAR Subtype C10), OTTHUMP00000058849, Receptor, ZNF32, alpha-2A-, ADRA2A (Adrenergic |
| known also as: |
ADRA2A |
| known also as: |
ADRA2, ADRA2R, ADRAR, ALPHA2AAR, Alpha-2A-Adrenergic Receptor, Alpha-2AAR Subtype C10), OTTHUMP00000058849, Receptor, ZNF32, alpha-2A-, Anti -ADRA2A (Adrenergic |
| Other names: |
Alpha-2 adrenergic receptor subtype C10, Alpha-2A adrenergic receptor, Alpha-2A adrenoreceptor, OTTHUMP00000020485, adrenergic, alpha-2 adrenergic receptor subtype C10, alpha-2-adrenergic receptor, alpha-2A adrenergic receptor, alpha-2A adrenoceptor, alpha-2A adrenoreceptor, alpha-2A-, alpha-2AAR subtype C10, platelet type, receptor, alpha-2A adrenergic receptor |
| Other gene names: |
ADRA2, ADRA2A, ADRA2R, ADRA2R, ADRAR, ADRAR, ALPHA2AAR, ZNF32, ADRA2A |
| Category: |
Antibodies |
| Clonality: |
Polyclonal |
| Clone: |
Polyclonal antibody |
| Host organism: |
Source: Human, Host: Goat |
| Species reactivity: |
Human, Mouse, Rat, Canine |
| Specificity and cross-reactivity: |
Species Crossreactivity: Canine, mouse and rat, Recognizes human ADRA2A |
| Purification method: |
Affinity Purified by immunoaffinity chromatography |
| Form/Appearance: |
0, 0, pH7, 02% sodium azide, 3, 5 mg/ml tris-saline, 5% BSA, Supplied as a liquid in 0 |
| Storage and shipping: |
Aliquots are stable for at least 12 months productone should be stored at -20 degrees Celsius, For long-term storage and to avoid repeated freezing and thawing, For maximum recovery of product, Further dilutions can be made in assay buffer, aliquot and For optimal long term storage, centrifuge the original vial after thawing and prior to removing the cap, productone should be kept at -20 degrees Celsius, Store at 4 degrees Celsius for short term storage |
| Tested for:: |
ELISA (EL/EIA) |
| Description: |
ADRA2, ADRA2R, ADRAR, ALPHA2AAR, Alpha-2A-Adrenergic Receptor, Alpha-2AAR Subtype C10) is a &alpha, OTTHUMP00000058849, ZNF32, alpha-2A- Receptor, - or alpha protein sometimes glycoprotein present in blood, The ADRA2A (Adrenergic |
| Advisory: |
For antibodies that are in liquid form or reconstituted lyophilized antibodies small amounts could become entrapped on the seal or the walls of the tube, Prior to use briefly centrifuge the vial to gather all the solution on the bottom, avoid cycles of freezing and thawing, please, In order to retain the quality and the affinity of productone unchanged |
| Gene target: |
ADRA2, ADRA2R, ADRAR, ALPHA2AAR, Alpha-2A-Adrenergic Receptor, Alpha-2AAR Subtype C10), OTTHUMP00000058849, ZNF32, alpha-2A Receptor, ADRA2A (Adrenergic |
| Short name: |
ADRA2, ADRA2R, ADRAR, ALPHA2AAR, Alpha-2A-Adrenergic Receptor, Alpha-2AAR Subtype C10), OTTHUMP00000058849, ZNF32, alpha-2A- Receptor, ADRA2A (Adrenergic |
| Alternative name: |
ADRA2, ADRA2R, ADRAR, ALPHA2AAR, OTTHUMP00000058849, Receptor, ZNF32, a-2A-, a-2A-Adrenergic Receptor, a-2AAR Subtype C10), adrenoceptor a 2A (Adrenergic |
| Alternative to gene target: |
ADRA2 and ADRA2R and ADRAR and ALPHA2AAR and ZNF32, ADRA2A and IDBG-89698 and ENSG00000150594 and 150, Adra2a and IDBG-177063 and ENSMUSG00000033717 and 11551, Plasma membranes, norepinephrine binding, this GO :0001819 and positive regulation of cytokine production and biological process this GO :0002526 and acute inflammatory response and biological process this GO :0004930 and G-protein coupled receptor activity and molecular function this GO :0004935 and adrenergic receptor activity and molecular function this GO :0004938 and alpha2-adrenergic receptor activity and molecular function this GO :0005515 and protein binding and molecular function this GO :0005737 and cytoplasm and cellular component this GO :0005886 and plasma membrane and cellular component this GO :0005887 and integral component of plasma membrane and cellular component this GO :0006112 and energy reserve metabolic process and biological process this GO :0006260 and DNA replication and biological process this GO :0006928 and cellular component movement and biological process this GO :0007165 and signal transduction and biological process this GO :0007186 and G-protein coupled receptor signaling pathway and biological process this GO :0007194 and negative regulation of adenylate cyclase activity and biological process this GO :0007265 and Ras protein signal transduction and biological process this GO :0007266 and Rho protein signal transduction and biological process this GO :0007565 and female pregnancy and biological process this GO :0007596 and blood coagulation and biological process this GO :0008284 and positive regulation of cell proliferation and biological process this GO :0010700 and negative regulation of norepinephrine secretion and biological process this GO :0016021 and integral component of membrane and cellular component this GO :0016323 and basolateral plasma membrane and cellular component this GO :0019229 and regulation of vasoconstriction and biological process this GO :0019901 and protein kinase binding and molecular function this GO :0030036 and actin cytoskeleton organization and biological process this GO :0030168 and platelet activation and biological process this GO :0030335 and positive regulation of cell migration and biological process this GO :0030818 and negative regulation of cAMP biosynthetic process and biological process this GO :0031692 and alpha-1B adrenergic receptor binding and molecular function this GO :0031696 and alpha-2C adrenergic receptor binding and molecular function this GO :0031996 and thioesterase binding and molecular function this GO :0032147 and activation of protein kinase activity and biological process this GO :0032148 and activation of protein kinase B activity and biological process this GO :0032795 and heterotrimeric G-protein binding and molecular function this GO :0032811 and negative regulation of epinephrine secretion and biological process this GO :0032870 and cellular response to hormone stimulus and biological process this GO :0035625 and epidermal growth factor-activated receptor transactivation by G-protein coupled receptor signaling pathway and biological process this GO :0042593 and glucose homeostasis and biological process this GO :0042596 and fear response and biological process this GO :0042803 and protein homodimerization activity and molecular function this GO :0043235 and receptor complex and cellular component this GO :0043268 and positive regulation of potassium ion transport and biological process this GO :0043406 and positive regulation of MAP kinase activity and biological process this GO :0044281 and small molecule metabolic process and biological process this GO :0045202 and synapse and cellular component this GO :0045741 and positive regulation of epidermal growth factor-activated receptor activity and biological process this GO :0045909 and positive regulation of vasodilation and biological process this GO :0045955 and negative regulation of calcium ion-dependent exocytosis and biological process this GO :0046676 and negative regulation of insulin secretion and biological process this GO :0046982 and protein heterodimerization activity and molecular function this GO :0050796 and regulation of insulin secretion and biological process this GO :0050892 and intestinal absorption and biological process this GO :0050955 and thermoception and biological process this GO :0050995 and negative regulation of lipid catabolic process and biological process this GO :0051044 and positive regulation of membrane protein ectodomain proteolysis and biological process this GO :0051379 and epinephrine binding and molecular function this GO :0051380 and norepinephrine binding and molecular function this GO :0051926 and negative regulation of calcium ion transport and biological process this GO :0061179 and negative regulation of insulin secretion involved in cellular response to glucose stimulus and biological process this GO :0070473 and negative regulation of uterine smooth muscle contraction and biological process this GO :0071878 and negative regulation of adrenergic receptor signaling pathway and biological process this GO :0071881 and adenylate cyclase-inhibiting adrenergic receptor signaling pathway and biological process this GO :0071882 and phospholipase C-activating adrenergic receptor signaling pathway and biological process this GO :0071883 and activation of MAPK activity by adrenergic receptor signaling pathway and biological process this GO :0090303 and positive regulation of wound healing and biological process this GO :1901020 and negative regulation of calcium ion transmembrane transporter activity and biological process, this GO :0004930 : G-protein coupled receptor activity, this GO :0004930 : G-protein coupled receptor activity and also this GO :0004935 : adrenergic receptor activity and also this GO :0004938 : alpha2-adrenergic receptor activity and also this GO :0005515 : protein binding and also this GO :0019901 : protein kinase binding and also this GO :0031692 : alpha-1B adrenergic receptor binding and also this GO :0031696 : alpha-2C adrenergic receptor binding and also this GO :0031996 : thioesterase binding and also this GO :0032795 : heterotrimeric G-protein binding and also this GO :0042803 : protein homodimerization activity and also this GO :0046982 : protein heterodimerization activity and also this GO :0051379 : epinephrine binding and also this GO :0051380 : norepinephrine binding, this GO :0004935 : adrenergic receptor activity, this GO :0004938 : alpha2-adrenergic receptor activity, this GO :0005515 : protein binding, this GO :0019901 : protein kinase binding, this GO :0031692 : alpha-1B adrenergic receptor binding, this GO :0031696 : alpha-2C adrenergic receptor binding, this GO :0031996 : thioesterase binding, this GO :0032795 : heterotrimeric G-protein binding, this GO :0042803 : protein homodimerization activity, this GO :0046982 : protein heterodimerization activity, this GO :0051379 : epinephrine binding, this GO :0051380 : norepinephrine binding, adrenoceptor alpha 2A |
| Identity: |
281 |
| Gene: |
ADRA2A |
More about : ADRA2A |
| Long gene name: |
adrenoceptor alpha 2A |
| Synonyms gene: |
ADRA2 ADRA2R |
| Synonyms gene name: |
adrenergic, alpha-2A-, receptor |
| Synonyms: |
ADRAR |
| Synonyms name: |
alpha-2AAR subtype C10 alpha-2A-adrenergic receptor |
| Locus: |
10q25, 2 |
| Discovery year: |
1990-09-10 |
| GenBank acession: |
AF284095 |
| Entrez gene record: |
150 |
| RefSeq identity: |
NM_000681 |
| Classification: |
Adrenoceptors |
| Havana BLAST/BLAT: |
OTTHUMG00000019050 |